Long- term efficacy and safety of vanadium in the treatment of type 1 diabetes.

@article{Soveid2013LongTE,
  title={Long- term efficacy and safety of vanadium in the treatment of type 1 diabetes.},
  author={Mahmood Soveid and Gholam Abbas Dehghani and Gholamhossein Ranjbar Omrani},
  journal={Archives of Iranian medicine},
  year={2013},
  volume={16 7},
  pages={408-11}
}
BACKGROUND Vanadium compounds are able to reduce blood glucose in experimentally- induced diabetic rats and type 2 diabetic patients, but data about their long- term safety and efficacy in diabetic patients are scarce. METHODS Fourteen type 1 diabetic patients received oral vanadyl sulfate (50 - 100 mg TID) for a period of 30 months. Fasting blood sugar (FBS), lipid levels, hematologic, and biochemical parameters were measured before and periodically during the treatment. RESULTS The daily… CONTINUE READING
Highly Cited
This paper has 49 citations. REVIEW CITATIONS

Topics

Statistics

0102030201620172018
Citations per Year

Citation Velocity: 8

Averaging 8 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.